ArticleHarm reduction journal2025
Willingness to use a drug checking service for cannabis and cannabis-based products: results from an online survey of people who regularly use cannabis in France.
Article in Harm reduction journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionAs cannabis is illegal in France, there is no regulation of the quality or composition of cannabis products on the illicit market. Although access to drug checking services for people who use drugs (PUD) is possible in several harm reduction (HR) structures for a large number of illicit substances, these structures seldom have the tools needed to adequately analyze organic substances such as cannabis.
methodsWe conducted an online survey among people who use cannabis. The survey questionnaire collected data on respondents' socio-demographic characteristics, use of cannabis and other psychoactive substances, and their willingness to use a cannabis drug checking service. We constructed a multivariable logistic regression model to explore factors associated with the latter dimension.
resultsAmong the 553 participants included in the analyses, 73.4% said they would be willing to use a cannabis checking service. Self-identifying as a woman was negatively associated with the desire to use such a service (ORa [95% CI] = 0.54 [0.35-0.86]). In contrast, having a tertiary education level (ORa [95% CI] = 2.14 [1.45-3.17]) and declaring therapeutic use of cannabis (sometimes/often: ORa [95% CI] = 1.71 [1.09-2.69]; always: ORa [95% CI] = 2.61 [1.25-5.49]) were positively associated factors.
conclusionsOur results highlight the strong willingness of many people who use cannabis in France to control the quality of the cannabis they obtain, particularly persons who use cannabis for therapeutic reasons. The implementation of adequate cannabis checking services in HR structures must take into account the diversity of populations that consume cannabis; in particular, they should be designed in such a way as that more women and persons with a lower level of education will use them.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.